Astal Laboratories Board of Directors

Get the latest insights into the leadership at Astal Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Sudheer Karna Kankanala Whole Time Director
Mrs. Shailaja Ravikanti Non Executive Director
Mr. Maggidi Venkatesh Non Executive Director
Dr. Hemachakrapani Bangaraiahgari Independent Director
Mr. Radhakishore Pandrangi Independent Director
Mr. Birendrakumar Sahoo Independent Director
Dr. Julius Paul Reinhard Paschke Independent Director

Astal Laboratories Share price

ASTALLTD

82.55

3.45 (-4.01%)
Last updated on 4 Sep, 2025 | 15:28 IST
BUYSELL
Today's High

86.90

Today's Low

82.00

52 Week Low

66.72

52 Week High

131.70

The current prices are delayed, login to your account for live prices

Astal Laboratories FAQs

The board at Astal Laboratories consists of experienced professionals, including Mr. Sudheer Karna Kankanala , Mrs. Shailaja Ravikanti , and others, overseeing the company’s strategic and corporate governance.

Directors at Astal Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Sudheer Karna Kankanala is the current chairman at Astal Laboratories.

Executive directors at Astal Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Astal Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Astal Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.